论文部分内容阅读
目的:分析冠心病心绞痛患者冠脉介入治疗前后生存质量及其相关因素。方法:分析2014年6月至2015月3月在本院接受冠脉介入治疗的104例冠心病心绞痛患者的临床资料,分别在治疗前后应用西雅图心绞痛调查问卷(SAQ)和健康调查简表(SF-36)对患者的生存质量进行评分,同时对患者的一般资料进行收集,分析冠脉介入治疗前后影响生存质量的相关因素。结果:治疗后,冠心病患者的SAQ评分以及SF-36评分均比治疗前更高,差异具有统计学意义(P<0.05);高血压、饮酒、吸烟是影响老年冠心病患者治疗前生存质量的重要因素,而性别、年龄以及血脂是影响患者治疗后生存质量的因素(P<0.05)。结论:冠脉介入方式治疗能够有效提升冠心病心绞痛患者生存质量,改善心绞痛症状,在介入治疗的同时,需叮嘱患者戒酒戒烟,严格控制血压、血脂等高危因素,以确保干预治疗的有效性。
Objective: To analyze the quality of life and its related factors before and after coronary intervention in patients with coronary heart disease and angina pectoris. Methods: The clinical data of 104 patients with coronary heart disease undergoing coronary intervention from June 2014 to March 2015 in our hospital were analyzed. Before and after treatment, the Seattle Angina Pectoris Questionnaire (SAQ) and Health Survey Profile (SF) -36) to score the quality of life of patients, and to collect the general information of patients, analyze the factors that affect the quality of life before and after coronary intervention. Results: After treatment, SAQ score and SF-36 score of CHD patients were higher than before treatment, the difference was statistically significant (P <0.05); hypertension, alcohol consumption and smoking were the factors influencing the quality of life before treatment in CHD patients (P <0.05). Sex, age and blood lipids were the factors affecting the quality of life of patients after treatment (P <0.05). Conclusion: PCI can improve the quality of life and improve the angina pectoris in patients with angina pectoris. At the same time of interventional therapy, patients should be told to quit smoking and strictly control the risk factors such as blood pressure and blood lipids so as to ensure the effectiveness of the intervention .